A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects

NCT04184492 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Clamp Study

Interventions

DRUG: GP-40081
DRUG: NovoMix® 30 Penfill®

Sponsor

Geropharm